Stephan K.
- Country
- Germany
- Department
- Medizinische Klinik II
Research Overview
- Phase II Trial Comparing Trifluridine/Tipiracil with Panitumumab Versus Trifluridine/Tipiracil with Bevacizumab in Metastatic Colorectal Cancer
- Phase III Randomized Open-Label Study of Pralsetinib vs. Standard Care in RET Fusion-Positive Metastatic Non-Small Cell Lung Cancer
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Neoadjuvant-Adjuvant Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma
Data & Insights
Has run more than one trial at 112 of 405 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating esophageal adenocarcinoma and gastroesophageal junction cancers, with particular focus on organ preservation approaches and innovative therapeutic combinations.
- Early-stage esophageal cancer management
- Gastric cancer treatment strategies
- Multimodal therapy approaches
Expertise extends to developing organ-preserving treatment protocols incorporating immunotherapy and chemoradiation.
Thoracic Oncology
Focus on advanced therapeutic approaches for non-small cell lung cancer, particularly targeting specific genetic alterations such as RET fusion-positive NSCLC.
- Targeted therapy development
- Precision medicine applications
- Treatment of metastatic disease
Specialized expertise in molecular-guided treatment strategies for lung cancer patients.
Colorectal Cancer
Dedicated to advancing treatment protocols for metastatic colorectal cancer and locally advanced colon cancer, investigating novel therapeutic combinations and timing strategies.
- First-line treatment optimization
- Preoperative therapy approaches
- Advanced disease management
Expertise in developing systematic approaches for both early-stage and metastatic colorectal cancer treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.